Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13


Monoclonal antibodies targeting different cell wall antigens of group B streptococcus mediate protection in both Fc-dependent and independent manner.

Senn BM, Visram Z, Meinke AL, Neubauer C, Gelbmann D, Sinzinger J, Hanner M, Lundberg U, Boisvert H, Reinscheid D, von Gabain A, Nagy E.

Vaccine. 2011 May 31;29(24):4116-24. doi: 10.1016/j.vaccine.2011.03.100. Epub 2011 Apr 13.


Immunological fingerprinting of group B streptococci: from circulating human antibodies to protective antigens.

Meinke AL, Senn BM, Visram Z, Henics TZ, Minh DB, Schüler W, Neubauer C, Gelbmann D, Noiges B, Sinzinger J, Hanner M, Dewasthaly S, Lundberg U, Hordnes K, Masoud H, Sevelda P, von Gabain A, Nagy E.

Vaccine. 2010 Oct 8;28(43):6997-7008. doi: 10.1016/j.vaccine.2010.08.041. Epub 2010 Aug 21.


Novel conserved group A streptococcal proteins identified by the antigenome technology as vaccine candidates for a non-M protein-based vaccine.

Fritzer A, Senn BM, Minh DB, Hanner M, Gelbmann D, Noiges B, Henics T, Schulze K, Guzman CA, Goodacre J, von Gabain A, Nagy E, Meinke AL.

Infect Immun. 2010 Sep;78(9):4051-67. doi: 10.1128/IAI.00295-10. Epub 2010 Jul 12.


The pneumococcal eukaryotic-type serine/threonine protein kinase StkP co-localizes with the cell division apparatus and interacts with FtsZ in vitro.

Giefing C, Jelencsics KE, Gelbmann D, Senn BM, Nagy E.

Microbiology. 2010 Jun;156(Pt 6):1697-707. doi: 10.1099/mic.0.036335-0. Epub 2010 Mar 11.


Composition of the ANTIGENome of Helicobacter pylori defined by human serum antibodies.

Meinke A, Storm M, Henics T, Gelbmann D, Prustomersky S, Kovács Z, Minh DB, Noiges B, Stierschneider U, Berger M, von Gabain A, Engstrand L, Nagy E.

Vaccine. 2009 May 26;27(25-26):3251-9. doi: 10.1016/j.vaccine.2009.01.066. Epub 2009 Feb 5.


Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies.

Giefing C, Meinke AL, Hanner M, Henics T, Bui MD, Gelbmann D, Lundberg U, Senn BM, Schunn M, Habel A, Henriques-Normark B, Ortqvist A, Kalin M, von Gabain A, Nagy E.

J Exp Med. 2008 Jan 21;205(1):117-31. doi: 10.1084/jem.20071168. Epub 2007 Dec 31.


High-affinity binding of the staphylococcal HarA protein to haptoglobin and hemoglobin involves a domain with an antiparallel eight-stranded beta-barrel fold.

Dryla A, Hoffmann B, Gelbmann D, Giefing C, Hanner M, Meinke A, Anderson AS, Koppensteiner W, Konrat R, von Gabain A, Nagy E.

J Bacteriol. 2007 Jan;189(1):254-64. Epub 2006 Oct 13.


Comparison of antibody repertoires against Staphylococcus aureus in healthy individuals and in acutely infected patients.

Dryla A, Prustomersky S, Gelbmann D, Hanner M, Bettinger E, Kocsis B, Kustos T, Henics T, Meinke A, Nagy E.

Clin Diagn Lab Immunol. 2005 Mar;12(3):387-98.


PIBF (progesterone induced blocking factor) is overexpressed in highly proliferating cells and associated with the centrosome.

Lachmann M, Gelbmann D, Kálmán E, Polgár B, Buschle M, Von Gabain A, Szekeres-Barthó J, Nagy E.

Int J Cancer. 2004 Oct 20;112(1):51-60.


Concomitant determination of absolute values of cellular protein amounts, synthesis rates, and turnover rates by quantitative proteome profiling.

Gerner C, Vejda S, Gelbmann D, Bayer E, Gotzmann J, Schulte-Hermann R, Mikulits W.

Mol Cell Proteomics. 2002 Jul;1(7):528-37.


Plasma from cancer patients featuring a characteristic protein composition mediates protection against apoptosis.

Vejda S, Posovszky C, Zelzer S, Peter B, Bayer E, Gelbmann D, Schulte-Hermann R, Gerner C.

Mol Cell Proteomics. 2002 May;1(5):387-93.


The Fas-induced apoptosis analyzed by high throughput proteome analysis.

Gerner C, Frohwein U, Gotzmann J, Bayer E, Gelbmann D, Bursch W, Schulte-Hermann R.

J Biol Chem. 2000 Dec 15;275(50):39018-26.

Supplemental Content

Loading ...
Support Center